Improving second-line therapy in aggressive non-Hodgkin's lymphomaGISSELBRECHT, Christian; MOUNIER, Nicolas.Seminars in oncology. 2004, Vol 31, pp 12-16, issn 0093-7754, 5 p., SUP2Article

Second-line treatment of patients with metastatic colorectal cancerROUGIER, Philippe; LEPERE, Celine.Seminars in oncology. 2005, Vol 32, Num 6, issn 0093-7754, S48-S54, SUP9Conference Paper

Do CA125 response criteria overestimate tumour response in second-line treatment of epithelial ovarian carcinoma?GRONLUND, B; HANSEN, H. H; HØGDALL, C et al.British journal of cancer. 2004, Vol 90, Num 2, pp 377-382, issn 0007-0920, 6 p.Article

Second-line treatment options in advanced non-small cell lung cancer : Current statusCULLEN, Michael.Seminars in oncology. 2006, Vol 33, Num 1, issn 0093-7754, S3-S8, SUP1Article

Use of novel second-line targeted therapies in non-small cell lung cancerMASSARELLI, Erminia; HERBST, Roy S.Seminars in oncology. 2006, Vol 33, Num 1, issn 0093-7754, S9-S16, SUP1Article

Phase III trial comparing three doses of docetaxel for second-line treatment of advanced breast cancerHARVEY, Vernon; MOURIDSEN, Henning; SEMIGLAZOV, Vladimir et al.Journal of clinical oncology. 2006, Vol 24, Num 31, pp 4963-4970, issn 0732-183X, 8 p.Article

Geographic variation in the second-line treatment of non-small cell lung cancerEDELMAN, Martin J; SEKINE, Ikuo; TAMURA, Tomohide et al.Seminars in oncology. 2006, Vol 33, Num 1, issn 0093-7754, S39-S44, SUP1Article

Caspofungin as second-line therapy for fever of unknown origin or invasive fungal infection following allogeneic stem cell transplantationTRENSCHEL, R; DITSCHKOWSKI, M; BEELEN, D. W et al.Bone marrow transplantation (Basingstoke). 2005, Vol 35, Num 6, pp 583-586, issn 0268-3369, 4 p.Article

Metastatic colorectal cancer : First- and second-line treatment in 2005ROUGIER, Philippe; LEPERE, Céline.Seminars in oncology. 2005, Vol 32, Num 6, pp S15-S20, issn 0093-7754, SUP8Conference Paper

Phase 2 trial of interferon-beta as second-line treatment of ovarian cancer, fallopian tube cancer, or primary carcinoma of the peritoneumMARKMAN, Maurie; BELINSON, Jerome; WEBSTER, Kenneth et al.Oncology. 2004, Vol 66, Num 5, pp 343-346, issn 0030-2414, 4 p.Article

The impact of induction chemotherapy on the outcome of second-line therapy with pemetrexed or docetaxel in patients with advanced non-small-cell lung cancerWEISS, G. J; ROSELL, R; KELLY, K et al.Annals of oncology. 2007, Vol 18, Num 3, pp 453-460, issn 0923-7534, 8 p.Article

Transdermal oestrogen therapy as a second-line hormonal intervention in prostate cancer : a bad experienceKANDOLA, Sandhir; ANYAMENE, Nicola; PAYNE, Heather et al.BJU international (Papier). 2007, Vol 99, Num 1, pp 53-55, issn 1464-4096, 3 p.Article

Sorafénib (Nexavar°) : Cancers du rein en deuxième ligne: Mieux évalué que le sunitinib = Sorafenib for second line renal carcinoma : a critical studyLa Revue Prescrire. 2007, Vol 27, Num 283, pp 325-327, issn 0247-7750, 3 p.Article

Management of recurrent ovarian cancer with systemic therapyPOVEDA, Andrés.European journal of cancer. Supplement (1990). 2007, Vol 5, Num 1, pp 29-36, issn 1359-6349, 8 p.Article

First-line 5-fluorouracil/folinic acid, oxaliplatin and irinotecan (FOLFOXIRI) does not impair the feasibility and the activity of second line treatments in metastatic colorectal cancerMASI, G; MARCUCCI, L; CUPINI, S et al.Annals of oncology. 2006, Vol 17, Num 8, pp 1249-1254, issn 0923-7534, 6 p.Article

Short-time infusion of oxaliplatin in combination with capecitabine (XELOX₃₀) as second-line therapy in patients with advanced colorectal cancer after failure to irinotecan and 5-fluorouracilPFEIFFER, P; SØRBYE, H; QVORTRUP, C et al.Annals of oncology. 2006, Vol 17, Num 2, pp 252-258, issn 0923-7534, 7 p.Article

Vinflunine : a new active drug for second-line treatment of advanced breast cancer. Results of a phase II and pharmacokinetic study in patients progressing after first-line anthracycline/ taxane-based chemotherapyCAMPONE, M; CORTES-FUNES, H; ASLANIS, V et al.British journal of cancer. 2006, Vol 95, Num 9, pp 1161-1166, issn 0007-0920, 6 p.Article

Actualités dans le cancer bronchique à petites cellulesPUJOL, Jean-Louis; SOUQUET, Pierre-Jean.Oncologie (Paris). 2006, Vol 8, issn 1292-3818, 9 p., SUP4Serial Issue

Clinical and endocrine data for goserelin plus anastrozole as second-line endocrine therapy for premenopausal advanced breast cancerFORWARD, D. P; CHEUNG, K. L; JACKSON, L et al.British journal of cancer. 2004, Vol 90, Num 3, pp 590-594, issn 0007-0920, 5 p.Article

Phase II trial of irinotecan/gemcitabine as second-line therapy for relapsed and refractory small-cell lung cancer : Cancer and Leukemia Group B Study 39902ROCHA-LIMA, C. M; HERNDON, J. E; LEE, M. E et al.Annals of oncology. 2007, Vol 18, Num 2, pp 331-337, issn 0923-7534, 7 p.Article

Phase II trial of sorafenib plus interferon alfa-2b as first-or second-line therapy in patients with metastatic renal cell cancerGOLLOB, Jared A; KIMRYN RATHMELL, W; RICHMOND, Tina M et al.Journal of clinical oncology. 2007, Vol 25, Num 22, pp 3288-3295, issn 0732-183X, 8 p.Article

The combination of letrozole and trastuzumab as first or second-line biological therapy produces durable responses in a subset of HER2 positive and ER positive advanced breast cancersMARCOM, P. Kelly; ISAACS, Claudine; HARRIS, Lyndsay et al.Breast cancer research and treatment. 2007, Vol 102, Num 1, pp 43-49, issn 0167-6806, 7 p.Article

A retrospective evaluation of second-line chemotherapy response in hormone-refractory prostate carcinoma : Second-line taxane-based therapy after first-line epothilone-B analog ixabepilone (BMS-247550) therapyROSENBERG, Jonathan E; GALSKY, Matthew D; ROHS, Nicholas C et al.Cancer. 2006, Vol 106, Num 1, pp 58-62, issn 0008-543X, 5 p.Article

First- and second-line therapy of metastatic colorectal cancerTERSTRIEP, Shelby; GROTHEY, Axel.Expert review of anticancer therapy. 2006, Vol 6, Num 6, pp 921-930, issn 1473-7140, 10 p.Article

Predictive factors for outcome in a phase II study of gefitinib in second-line treatment of advanced esophageal cancer patientsJANMAAT, Maarten L; GALLEGOS-RUIZ, Mariëlle I; RODRIGUEZ, José A et al.Journal of clinical oncology. 2006, Vol 24, Num 10, pp 1612-1619, issn 0732-183X, 8 p.Article